S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.50 (+0.40%)
AAPL   122.16 (-0.63%)
MSFT   214.36 (+0.06%)
FB   279.85 (-0.71%)
GOOGL   1,822.73 (+0.05%)
AMZN   3,162.62 (-0.76%)
TSLA   600.58 (+1.21%)
NVDA   542.39 (+1.22%)
BABA   267.07 (+0.06%)
CGC   28.64 (+0.03%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.02 (+1.85%)
T   29.55 (+1.09%)
NIO   42.94 (-5.31%)
F   9.33 (+1.30%)
ACB   10.96 (-2.49%)
BA   232.71 (-1.89%)
NFLX   498.65 (+0.23%)
GILD   61.57 (+1.17%)
DIS   153.85 (+0.40%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.50 (+0.40%)
AAPL   122.16 (-0.63%)
MSFT   214.36 (+0.06%)
FB   279.85 (-0.71%)
GOOGL   1,822.73 (+0.05%)
AMZN   3,162.62 (-0.76%)
TSLA   600.58 (+1.21%)
NVDA   542.39 (+1.22%)
BABA   267.07 (+0.06%)
CGC   28.64 (+0.03%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.02 (+1.85%)
T   29.55 (+1.09%)
NIO   42.94 (-5.31%)
F   9.33 (+1.30%)
ACB   10.96 (-2.49%)
BA   232.71 (-1.89%)
NFLX   498.65 (+0.23%)
GILD   61.57 (+1.17%)
DIS   153.85 (+0.40%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.50 (+0.40%)
AAPL   122.16 (-0.63%)
MSFT   214.36 (+0.06%)
FB   279.85 (-0.71%)
GOOGL   1,822.73 (+0.05%)
AMZN   3,162.62 (-0.76%)
TSLA   600.58 (+1.21%)
NVDA   542.39 (+1.22%)
BABA   267.07 (+0.06%)
CGC   28.64 (+0.03%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.02 (+1.85%)
T   29.55 (+1.09%)
NIO   42.94 (-5.31%)
F   9.33 (+1.30%)
ACB   10.96 (-2.49%)
BA   232.71 (-1.89%)
NFLX   498.65 (+0.23%)
GILD   61.57 (+1.17%)
DIS   153.85 (+0.40%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.50 (+0.40%)
AAPL   122.16 (-0.63%)
MSFT   214.36 (+0.06%)
FB   279.85 (-0.71%)
GOOGL   1,822.73 (+0.05%)
AMZN   3,162.62 (-0.76%)
TSLA   600.58 (+1.21%)
NVDA   542.39 (+1.22%)
BABA   267.07 (+0.06%)
CGC   28.64 (+0.03%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.02 (+1.85%)
T   29.55 (+1.09%)
NIO   42.94 (-5.31%)
F   9.33 (+1.30%)
ACB   10.96 (-2.49%)
BA   232.71 (-1.89%)
NFLX   498.65 (+0.23%)
GILD   61.57 (+1.17%)
DIS   153.85 (+0.40%)
Log in
NASDAQ:KIDS

OrthoPediatrics Stock Forecast, Price & News

$44.51
+1.95 (+4.58 %)
(As of 12/4/2020 03:59 PM ET)
Add
Compare
Today's Range
$41.19
Now: $44.51
$44.86
50-Day Range
$41.02
MA: $46.13
$49.77
52-Week Range
$32.21
Now: $44.51
$55.98
Volume12,313 shs
Average Volume148,707 shs
Market Capitalization$870.39 million
P/E RatioN/A
Dividend YieldN/A
Beta0.78
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, and QuickPack. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
OrthoPediatrics logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.46 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379
Employees94

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$72.55 million
Book Value$12.24 per share

Profitability

Net Income$-13,730,000.00

Miscellaneous

Market Cap$870.39 million
Next Earnings Date3/3/2021 (Estimated)
OptionableNot Optionable
$44.51
+1.95 (+4.58 %)
(As of 12/4/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OrthoPediatrics (NASDAQ:KIDS) Frequently Asked Questions

How has OrthoPediatrics' stock price been impacted by COVID-19 (Coronavirus)?

OrthoPediatrics' stock was trading at $39.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, KIDS stock has increased by 11.7% and is now trading at $44.40.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of OrthoPediatrics?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for OrthoPediatrics
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than OrthoPediatrics?

Wall Street analysts have given OrthoPediatrics a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but OrthoPediatrics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is OrthoPediatrics' next earnings date?

OrthoPediatrics is scheduled to release its next quarterly earnings announcement on Wednesday, March 3rd 2021.
View our earnings forecast for OrthoPediatrics
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) released its quarterly earnings results on Wednesday, November, 11th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.31) by $0.07. The business earned $22.21 million during the quarter, compared to analyst estimates of $19.73 million. OrthoPediatrics had a negative return on equity of 11.57% and a negative net margin of 34.26%.
View OrthoPediatrics' earnings history
.

What price target have analysts set for KIDS?

6 equities research analysts have issued twelve-month target prices for OrthoPediatrics' shares. Their forecasts range from $48.00 to $57.00. On average, they anticipate OrthoPediatrics' stock price to reach $53.50 in the next year. This suggests a possible upside of 20.5% from the stock's current price.
View analysts' price targets for OrthoPediatrics
.

Who are some of OrthoPediatrics' key competitors?

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), The Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

Who are OrthoPediatrics' key executives?

OrthoPediatrics' management team includes the following people:
  • Mr. Mark C. Throdahl, CEO & Director (Age 69, Pay $604.5k)
  • Mr. David R. Bailey, Pres (Age 41, Pay $444.36k)
  • Mr. Fred L. Hite, CFO, Principal Financial & Accounting Officer, COO and Director (Age 52, Pay $532.21k)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 50, Pay $426k)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 50, Pay $444.91k)
  • Mr. Joel Batts, Sr. VP of Science & Technology
  • Dr. Peter F. Armstrong M.D., Chief Medical Officer & Chair of Surgeon Advisory Board (Age 73)
  • Mr. Joe Hauser, Sr. VP & GM of Trauma & Deformity Correction
  • Mr. Mark Karshner, Sr. VP of International Sales

When did OrthoPediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is OrthoPediatrics' stock symbol?

OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS."

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (5.06%), BlackRock Inc. (4.55%), Massachusetts Financial Services Co. MA (2.83%), Summit Partners Public Asset Management LLC (2.77%), Wells Fargo & Company MN (2.25%) and Wasatch Advisors Inc. (1.86%). Company insiders that own OrthoPediatrics stock include Bernie B Berry III, Daniel J Gerritzen, David R Bailey, Gregory A Odle, Mark C Throdahl and Stephen F Burns.
View institutional ownership trends for OrthoPediatrics
.

Which institutional investors are selling OrthoPediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Morgan Stanley, Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, Squarepoint Ops LLC, CWM LLC, Oak Ridge Investments LLC, and SG Americas Securities LLC. Company insiders that have sold OrthoPediatrics company stock in the last year include Bernie B Berry III, Daniel J Gerritzen, David R Bailey, Gregory A Odle, Mark C Throdahl, and Stephen F Burns.
View insider buying and selling activity for OrthoPediatrics
.

Which institutional investors are buying OrthoPediatrics stock?

KIDS stock was acquired by a variety of institutional investors in the last quarter, including Royce & Associates LP, First Light Asset Management LLC, Summit Partners Public Asset Management LLC, Charles Schwab Investment Management Inc., State Street Corp, Riverbridge Partners LLC, BlackRock Inc., and Wells Fargo & Company MN.
View insider buying and selling activity for OrthoPediatrics
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OrthoPediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $44.40.

How big of a company is OrthoPediatrics?

OrthoPediatrics has a market capitalization of $868.24 million and generates $72.55 million in revenue each year. The company earns $-13,730,000.00 in net income (profit) each year or ($0.87) on an earnings per share basis. OrthoPediatrics employs 94 workers across the globe.

What is OrthoPediatrics' official website?

The official website for OrthoPediatrics is www.orthopediatrics.com.

How can I contact OrthoPediatrics?

OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.